Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection

被引：7
|
作者：
Bai, Ya Mei [1 ]
Chen, Tzu Ting
Lin, Wen Kuo
Chang, Wen-Ho
Wu, Bojian
Hung, Chih Hung
Chou, Pesus
Chen, Jen-Yeu
机构：
[1] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
[2] Yu Li Vet Hosp, Dept Psychiat, Hualien, Taiwan
[3] Kaohsiung Med Univ, Grad Inst Behav Sci, Kaohsiung, Taiwan
[4] Buddhist Tzu Chi Gen Hosp, Dept Psychiat, Da Lin, Taiwan
[5] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 27卷 / 03期
关键词：
D O I：
10.1097/01.jcp.0000270090.55156.7a
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：306 / 308
页数：3
相关论文
共 50 条
  • [21] Explicit review of risperidone long-acting injection prescribing practice
    Wheeler, A.
    Vanderpyl, J.
    Carswell, C.
    Stojkovic, M.
    Robinson, E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (06) : 651 - 663
  • [22] Long-acting risperidone injection reduces healthcare resource use
    Hagström, P
    Mehnert, A
    Leal, A
    Gefvert, O
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 98 - 98
  • [23] Prognostic indicators for early discontinuation of risperidone long-acting injection
    Patel, MX
    Young, C
    Samele, C
    Taylor, DM
    David, AS
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (04) : 233 - 239
  • [24] Patients' acceptance of the deltoid application of risperidone long-acting injection
    Heres, Stephan
    Frobose, Teresa
    Hamann, Johannes
    Leucht, Stefan
    Maino, Katja
    Reichhart, Tatjana
    Stiegler, Michaela
    Kissling, Werner
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (12) : 897 - 901
  • [25] Long-acting risperidone, efficacy and safety of a new risperidone formulation
    Chinchilla, A
    Vega, M
    Quintero, J
    Yañez, R
    Correas, J
    Crespo, D
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S238 - S238
  • [26] The influence of switching from oral risperidone to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia
    Suzuki, Hidenobu
    Gen, Keishi
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (01) : 23 - 29
  • [27] New for old? Risperidone long-acting injection in older patients
    Hudson-Jessop, Pamela
    Hughes, Brendan
    Brinkley, Neridah
    AUSTRALASIAN PSYCHIATRY, 2007, 15 (06) : 461 - 464
  • [28] Risperidone long-acting injection: Predictors of relapse at one year
    Patel, MX
    Young, C
    David, AS
    Taylor, DM
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 79 - 79
  • [29] Cost-effectiveness evaluation of long-acting risperidone injection
    Edwards, N
    Rupnow, M
    Pashos, CL
    Botteman, MF
    Locklear, J
    Diamond, R
    VALUE IN HEALTH, 2004, 7 (03) : 270 - 270
  • [30] NATURALISTIC OBSERVATIONAL STUDY OF PATIENTS RECEIVING RISPERIDONE LONG-ACTING INJECTION (RLAI)
    Gupta, N.
    Riley, C.
    Agell, I.
    EUROPEAN PSYCHIATRY, 2009, 24
12345